A number of studies have previously provided evidence on the Anti-inflammatory properties of plant-derived compounds that can prevent lung injury. In this study, we attempted to analyze the therapeutic effects of PM 014 on inflammation and pulmonary fibrosis in COVID-19 as well as describing the treatment of one of the most challenging problems related to the coronavirus-19 (COVID-19). We believe that having a close look at all angles of the proposed mechanism goes beyond the physiological consequences of a way to design new strategies for providing an appropriate treatment.
|Original language||English (US)|
|Number of pages||4|
|Journal||Journal of Advances in Medical and Biomedical Research|
|State||Published - May 1 2022|
All Science Journal Classification (ASJC) codes
- Pulmonary fibrosis